| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.3 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |